Anthem Pulls Plug on Mail Policy

Article

Health insurer Anthem pulled the plug on a policy in California that would require patients to get their specialty drugs through the mail.

Health insurer Anthem pulled the plug on a policy in California that would require patients to get their specialty drugs through the mail.

It’s March 1st, and a policy from Anthem Blue Cross that was supposed to go into effect today restricting patients from getting their specialty drugs from a pharmacy of their choice has been suspended.

We covered the policy issue here, and after much publicity, the health plan decided to suspend the policy, according to LA Times’ David Lazarus.

Patients will not be required to get their specialty medications through CuraScript for the time being. Lazarus reported that the insurer sent letters informing patients of the policy suspension, and based on input from its members, the company has “eliminated the stated March 1, 2013, required date to use CuraScript for such additional specialty medications.”

"We are working diligently to enhance and make plain the many benefits of our Specialty Pharmacy program, and will clearly communicate all aspects of the Specialty Pharmacy program to you before any changes to the existing program are put in place," the letter asserted. "Again, nothing will change on March 1 as previously communicated.”

Related Videos
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.